Meghan Thompson

@MCThompsonMD

Oncologist @MSKCancerCenter🩸🧬 Alum @MSKCancerCenter @PennIMResidents @OhioStateMed @Princeton. Opinions are my own.

New York, New York Joined December 2019

492 Following 681 Followers 102 Posts

Latest posts 5

Pinned post

Meghan Thompson @MCThompsonMD Feb 23, 2022

Now in @NEJM from @AbdelWahablab @TaylorJ_MD in collaboration w/ MSK CLL program @anthonymatomd. We have discovered novel BTK mutations that confer resistance to pirtobrutinib CLL pts. Grateful to be part of this incredible #teamscience with @ewang2323 & Xialoi Mi & many others

Meghan Thompson @MCThompsonMD May 7, 2025

Looking forward to discussing updates in CLL at this event!

PeerView Verified account @PeerView May 7, 2025

CLL Community Conversations on Modern Care: Participate in a dynamic #PeerView TownHall and engage in meaningful dialogue on real-world challenges in #CLL care. 5/31 at 6:30 PM CDT. Produced w/ @CLLSociety. bit.ly/CLL-25T #ASCO25 @NitinJainMD @MCThompsonMD @KrishPatelMD

View quoted post on X

Meghan Thompson @MCThompsonMD Feb 12, 2025

Looking forward to this program!

Adam Kittai @AdamKittai Feb 12, 2025

I am pleased to announce that I will be speaking @ Update on Chronic Lymphocytic Leukemia (CLL) on February 21. For more information or to register, please visit cancercare.org/connect. @ErmannMD @MCThompsonMD
View quoted post on X

Meghan Thompson @MCThompsonMD May 6, 2024

Great exchange of ideas at #HOPLive24

chadi nabhan MD, MBA, FACP Verified account @chadinabhan May 5, 2024

Only at the #HOPLive24 meeting in Chicago where you could spot @VincentRK playing guitar while @AaronGoodman33 attempting to sing.
Science & Fun only at #HOPLive24
Thanks to all faculty who traveled here and safe trip home. 🙏 @Blood_Cancers
@Rfonsi1 @szusmani @sanamloghavi

View quoted post on X

Meghan Thompson @MCThompsonMD Feb 2, 2024

Overcoming resistance to BTK inhibitors remains a critical unmet need for CLL pts. Great collaborative effort to further understand mechanisms of BTKi resistance and proof of concept work showing BTK degraders are a promising therapeutic modality that may overcome resistance

Abdel-Wahab Lab @AbdelWahablab Feb 1, 2024

Excited to announce our collaborative paper with @TaylorJ_MD and @Nurix_Tx out today in @ScienceMagazine:

science.org/doi/10.1126/sc…
View quoted post on X